Market Closed

RNAC
Cartesian Therapeutics
$ 6.35
-0.16%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Cartesian Therapeutics News

Latest Cartesian Therapeutics Stock News & RNAC Headlines

Wall Street Analysts See a 379.63% Upside in Cartesian Therapeutics, Inc. (RNAC): Can the Stock Really Move This High?
5 days ago | zacks.com
Cartesian Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
10 days ago | globenewswire.com
Cartesian Therapeutics Announces New Employment Inducement Grant
12 days ago | globenewswire.com
Cartesian Therapeutics (NASDAQ:RNAC) versus Syndax Pharmaceuticals (NASDAQ:SNDX) Critical Comparison
a month ago | defenseworld.net
Cartesian Therapeutics Announces New Employment Inducement Grants
a month ago | globenewswire.com
Cartesian Therapeutics Announces Additional Retreatment Data for Descartes-08 Highlighting Deep and Durable Responses in Patients with Myasthenia Gravis
2 months ago | globenewswire.com
Cartesian Therapeutics Announces New Employment Inducement Grants
2 months ago | globenewswire.com
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
2 months ago | globenewswire.com
Cartesian Therapeutics Announces New Employment Inducement Grants
3 months ago | globenewswire.com
Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
3 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

RNAC
Cartesian Therapeutics
$ 6.35
-0.16%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago